{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:43:59Z","timestamp":1786981439140,"version":"build-2736575974"},"reference-count":174,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81973626, No. 81774059"],"award-info":[{"award-number":["No. 81973626, No. 81774059"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81973626, No. 81774059"],"award-info":[{"award-number":["No. 81973626, No. 81774059"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81973626, No. 81774059"],"award-info":[{"award-number":["No. 81973626, No. 81774059"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81973626, No. 81774059"],"award-info":[{"award-number":["No. 81973626, No. 81774059"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81973626, No. 81774059"],"award-info":[{"award-number":["No. 81973626, No. 81774059"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81973626, No. 81774059"],"award-info":[{"award-number":["No. 81973626, No. 81774059"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Tianjin Municipal Science and Technology Commission of China","award":["No. 21JCYBJC01620"],"award-info":[{"award-number":["No. 21JCYBJC01620"]}]},{"name":"Tianjin Municipal Science and Technology Commission of China","award":["No. 21JCYBJC01620"],"award-info":[{"award-number":["No. 21JCYBJC01620"]}]},{"name":"Tianjin Municipal Science and Technology Commission of China","award":["No. 21JCYBJC01620"],"award-info":[{"award-number":["No. 21JCYBJC01620"]}]},{"name":"Tianjin Health Committee","award":["No. 2021099"],"award-info":[{"award-number":["No. 2021099"]}]},{"name":"Tianjin Health Committee","award":["No. 2021099"],"award-info":[{"award-number":["No. 2021099"]}]},{"name":"Tianjin Health Committee","award":["No. 2021099"],"award-info":[{"award-number":["No. 2021099"]}]},{"name":"Tianjin Education Committee","award":["No. 2021KJ146"],"award-info":[{"award-number":["No. 2021KJ146"]}]},{"name":"Tianjin Education Committee","award":["No. 2021KJ146"],"award-info":[{"award-number":["No. 2021KJ146"]}]},{"name":"Tianjin Education Committee","award":["No. 2021KJ146"],"award-info":[{"award-number":["No. 2021KJ146"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s11010-023-04853-6","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T07:02:16Z","timestamp":1696316536000},"page":"2217-2243","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The gut microbiome: an important role in neurodegenerative diseases and their therapeutic advances"],"prefix":"10.1007","volume":"479","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6223-481X","authenticated-orcid":false,"given":"Songlin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3918-6722","authenticated-orcid":false,"given":"Linna","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1579-2800","authenticated-orcid":false,"given":"Jie","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3049-5000","authenticated-orcid":false,"given":"Yuying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8415-9937","authenticated-orcid":false,"given":"Rong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3722-6524","authenticated-orcid":false,"given":"Yunsha","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2270-2911","authenticated-orcid":false,"given":"Shixin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,3]]},"reference":[{"key":"4853_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nn.4476","volume":"20","author":"TC Fung","year":"2017","unstructured":"Fung TC, Olson CA, Hsiao EY (2017) Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci 20:145\u2013155","journal-title":"Nat Neurosci"},{"key":"4853_CR2","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.immuni.2017.04.008","volume":"46","author":"Y Belkaid","year":"2017","unstructured":"Belkaid Y, Harrison OJ (2017) Homeostatic Immunity and the Microbiota. Immunity 46:562\u2013576","journal-title":"Immunity"},{"key":"4853_CR3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12020-018-1605-5","volume":"61","author":"A Pascale","year":"2018","unstructured":"Pascale A, Marchesi N, Marelli C, Coppola A, Luzi L et al (2018) Microbiota and metabolic diseases. Endocrine 61:357\u2013371","journal-title":"Endocrine"},{"key":"4853_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1084\/jem.20180794","volume":"216","author":"R Abdel-Haq","year":"2019","unstructured":"Abdel-Haq R, Schlachetzki JCM, Glass CK, Mazmanian SK (2019) Microbiome-microglia connections via the gut-brain axis. J Exp Med 216:41\u201359","journal-title":"J Exp Med"},{"key":"4853_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","volume":"464","author":"J Qin","year":"2010","unstructured":"Qin J, Li R, Raes J, Arumugam M, Burgdorf KS et al (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59\u201365","journal-title":"Nature"},{"key":"4853_CR6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/ana.24901","volume":"81","author":"H Tremlett","year":"2017","unstructured":"Tremlett H, Bauer KC, Appel-Cresswell S, Finlay BB, Waubant E (2017) The gut microbiome in human neurological disease: A review. Ann Neurol 81:369\u2013382","journal-title":"Ann Neurol"},{"key":"4853_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","volume":"19","author":"Y Fan","year":"2021","unstructured":"Fan Y, Pedersen O (2021) Gut microbiota in human metabolic health and disease. Nat Rev Microbiol 19:55\u201371","journal-title":"Nat Rev Microbiol"},{"key":"4853_CR8","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.chom.2015.04.011","volume":"17","author":"TR Sampson","year":"2015","unstructured":"Sampson TR, Mazmanian SK (2015) Control of brain development, function, and behavior by the microbiome. Cell Host Microbe 17:565\u2013576","journal-title":"Cell Host Microbe"},{"key":"4853_CR9","doi-asserted-by":"publisher","first-page":"5486","DOI":"10.3748\/wjg.v23.i30.5486","volume":"23","author":"MC Cenit","year":"2017","unstructured":"Cenit MC, Sanz Y, Codo\u00f1er-Franch P (2017) Influence of gut microbiota on neuropsychiatric disorders. World J Gastroenterol 23:5486\u20135498","journal-title":"World J Gastroenterol"},{"key":"4853_CR10","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG et al (2019) Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol 15:565\u2013581","journal-title":"Nat Rev Neurol"},{"key":"4853_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S1474-4422(19)30356-4","volume":"19","author":"JF Cryan","year":"2020","unstructured":"Cryan JF, O\u2019Riordan KJ, Sandhu K, Peterson V, Dinan TG (2020) The gut microbiome in neurological disorders. The Lancet Neurology 19:179\u2013194","journal-title":"The Lancet Neurology"},{"key":"4853_CR12","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","volume":"99","author":"JF Cryan","year":"2019","unstructured":"Cryan JF, O\u2019Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS et al (2019) The Microbiota-Gut-Brain Axis. Physiol Rev 99:1877\u20132013","journal-title":"Physiol Rev"},{"key":"4853_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrgastro.2016.191","volume":"14","author":"N Powell","year":"2017","unstructured":"Powell N, Walker MM, Talley NJ (2017) The mucosal immune system: master regulator of bidirectional gut-brain communications. Nat Rev Gastroenterol Hepatol 14:143\u2013159","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4853_CR14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nri3228","volume":"12","author":"RL Gallo","year":"2012","unstructured":"Gallo RL, Hooper LV (2012) Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol 12:503\u2013516","journal-title":"Nat Rev Immunol"},{"key":"4853_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.03.010","volume":"60","author":"A Varatharaj","year":"2017","unstructured":"Varatharaj A, Galea I (2017) The blood-brain barrier in systemic inflammation. Brain Behav Immun 60:1\u201312","journal-title":"Brain Behav Immun"},{"key":"4853_CR16","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.cgh.2018.10.002","volume":"17","author":"V Osadchiy","year":"2019","unstructured":"Osadchiy V, Martin CR, Mayer EA (2019) The Gut-Brain Axis and the Microbiome: Mechanisms and Clinical Implications. Clin Gastroenterol Hepatol 17:322\u2013332","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4853_CR17","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1053\/j.gastro.2016.10.046","volume":"152","author":"KN Browning","year":"2017","unstructured":"Browning KN, Verheijden S, Boeckxstaens GE (2017) The Vagus Nerve in Appetite Regulation, Mood, and Intestinal Inflammation. Gastroenterology 152:730\u2013744","journal-title":"Gastroenterology"},{"key":"4853_CR18","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3389\/fimmu.2017.01452","volume":"8","author":"B Bonaz","year":"2017","unstructured":"Bonaz B, Sinniger V, Pellissier S (2017) The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the Gastrointestinal Tract. Front Immunol 8:1452","journal-title":"Front Immunol"},{"key":"4853_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.brainres.2018.01.012","volume":"1693","author":"CR Cawthon","year":"2018","unstructured":"Cawthon CR, de La Serre CB (2018) Gut bacteria interaction with vagal afferents. Brain Res 1693:134\u2013139","journal-title":"Brain Res"},{"key":"4853_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12026-015-8718-1","volume":"63","author":"VA Pavlov","year":"2015","unstructured":"Pavlov VA, Tracey KJ (2015) Neural circuitry and immunity. Immunol Res 63:38\u201357","journal-title":"Immunol Res"},{"key":"4853_CR21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.2147\/NDT.S243551","volume":"16","author":"S Liu","year":"2020","unstructured":"Liu S, Guo R, Liu F, Yuan Q, Yu Y, Ren F (2020) Gut Microbiota Regulates Depression-Like Behavior in Rats Through the Neuroendocrine-Immune-Mitochondrial Pathway. Neuropsychiatr Dis Treat 16:859\u2013869","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"Suppl 1","key":"4853_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/jnc.13062","volume":"136","author":"Z Chen","year":"2016","unstructured":"Chen Z, Trapp BD (2016) Microglia and neuroprotection. J Neurochem 136(Suppl 1):10\u201317","journal-title":"J Neurochem"},{"key":"4853_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2020.103493","volume":"105","author":"TJ Wenzel","year":"2020","unstructured":"Wenzel TJ, Gates EJ, Ranger AL, Klegeris A (2020) Short-chain fatty acids (SCFAs) alone or in combination regulate select immune functions of microglia-like cells. Mol Cell Neurosci 105:103493","journal-title":"Mol Cell Neurosci"},{"key":"4853_CR24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.yfrne.2018.04.002","volume":"51","author":"S Cussotto","year":"2018","unstructured":"Cussotto S, Sandhu KV, Dinan TG, Cryan JF (2018) The Neuroendocrinology of the Microbiota-Gut-Brain Axis: A Behavioural Perspective. Front Neuroendocrinol 51:80\u2013101","journal-title":"Front Neuroendocrinol"},{"key":"4853_CR25","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1096\/fj.14-259598","volume":"29","author":"CS Reigstad","year":"2015","unstructured":"Reigstad CS, Salmonson CE, Rainey JF 3rd, Szurszewski JH, Linden DR et al (2015) Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. Faseb j 29:1395\u20131403","journal-title":"Faseb j"},{"key":"4853_CR26","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/advances\/nmz127","volume":"11","author":"K Gao","year":"2020","unstructured":"Gao K, Mu CL, Farzi A, Zhu WY (2020) Tryptophan Metabolism: A Link Between the Gut Microbiota and Brain. Adv Nutr 11:709\u2013723","journal-title":"Adv Nutr"},{"key":"4853_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fnsys.2013.00009","volume":"7","author":"M Matsumoto","year":"2013","unstructured":"Matsumoto M, Kibe R, Ooga T, Aiba Y, Sawaki E et al (2013) Cerebral low-molecular metabolites influenced by intestinal microbiota: a pilot study. Front Syst Neurosci 7:9","journal-title":"Front Syst Neurosci"},{"key":"4853_CR28","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1189\/jlb.3RI0516-222R","volume":"100","author":"S Gorjifard","year":"2016","unstructured":"Gorjifard S, Goldszmid RS (2016) Microbiota-myeloid cell crosstalk beyond the gut. J Leukoc Biol 100:865\u2013879","journal-title":"J Leukoc Biol"},{"key":"4853_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s13311-017-0585-0","volume":"15","author":"G Lach","year":"2018","unstructured":"Lach G, Schellekens H, Dinan TG, Cryan JF (2018) Anxiety, Depression, and the Microbiome: A Role for Gut Peptides. Neurotherapeutics 15:36\u201359","journal-title":"Neurotherapeutics"},{"key":"4853_CR30","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.cell.2016.10.027","volume":"167","author":"G Sharon","year":"2016","unstructured":"Sharon G, Sampson TR, Geschwind DH, Mazmanian SK (2016) The Central Nervous System and the Gut Microbiome. Cell 167:915\u2013932","journal-title":"Cell"},{"key":"4853_CR31","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1113\/JP273106","volume":"595","author":"TG Dinan","year":"2017","unstructured":"Dinan TG, Cryan JF (2017) Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration. J Physiol 595:489\u2013503","journal-title":"J Physiol"},{"key":"4853_CR32","doi-asserted-by":"publisher","first-page":"P1473","DOI":"10.1016\/j.jalz.2019.06.4115","volume":"15","author":"WS Weidner","year":"2019","unstructured":"Weidner WS, Barbarino P (2019) THE STATE OF THE ART OF DEMENTIA RESEARCH: NEW FRONTIERS. Alzheimers Dement 15:P1473","journal-title":"Alzheimers Dement"},{"key":"4853_CR33","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.2147\/IJN.S200490","volume":"14","author":"S Tiwari","year":"2019","unstructured":"Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M (2019) Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine 14:5541\u20135554","journal-title":"Int J Nanomedicine"},{"key":"4853_CR34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener 14:32","journal-title":"Mol Neurodegener"},{"key":"4853_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2019.100966","volume":"56","author":"CF Pereira","year":"2019","unstructured":"Pereira CF, Santos AE, Moreira PI, Pereira AC, Sousa FJ et al (2019) Is Alzheimer\u2019s disease an inflammasomopathy? Ageing Res Rev 56:100966","journal-title":"Ageing Res Rev"},{"key":"4853_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101409","volume":"70","author":"KM Wu","year":"2021","unstructured":"Wu KM, Zhang YR, Huang YY, Dong Q, Tan L, Yu JT (2021) The role of the immune system in Alzheimer\u2019s disease. Ageing Res Rev 70:101409","journal-title":"Ageing Res Rev"},{"key":"4853_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arr.2019.01.002","volume":"50","author":"S Bradburn","year":"2019","unstructured":"Bradburn S, Murgatroyd C, Ray N (2019) Neuroinflammation in mild cognitive impairment and Alzheimer\u2019s disease: A meta-analysis. Ageing Res Rev 50:1\u20138","journal-title":"Ageing Res Rev"},{"key":"4853_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101317","volume":"68","author":"XH Qian","year":"2021","unstructured":"Qian XH, Song XX, Liu XL, Chen SD, Tang HD (2021) Inflammatory pathways in Alzheimer\u2019s disease mediated by gut microbiota. Ageing Res Rev 68:101317","journal-title":"Ageing Res Rev"},{"key":"4853_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.683068","volume":"12","author":"L van Olst","year":"2021","unstructured":"van Olst L, Roks SJM, Kamermans A, Verhaar BJH, van der Geest AM et al (2021) Contribution of Gut Microbiota to Immunological Changes in Alzheimer\u2019s Disease. Front Immunol 12:683068","journal-title":"Front Immunol"},{"key":"4853_CR40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.08.019","volume":"49","author":"A Cattaneo","year":"2017","unstructured":"Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N et al (2017) Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging 49:60\u201368","journal-title":"Neurobiol Aging"},{"key":"4853_CR41","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.bbi.2019.05.008","volume":"80","author":"P Liu","year":"2019","unstructured":"Liu P, Wu L, Peng G, Han Y, Tang R et al (2019) Altered microbiomes distinguish Alzheimer\u2019s disease from amnestic mild cognitive impairment and health in a Chinese cohort. Brain Behav Immun 80:633\u2013643","journal-title":"Brain Behav Immun"},{"key":"4853_CR42","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3233\/JAD-201497","volume":"81","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Wang Y, Quan M, Zhao H, Jia J (2021) Gut Microbiota Changes and Their Correlation with Cognitive and Neuropsychiatric Symptoms in Alzheimer\u2019s Disease. J Alzheimers Dis 81:583\u2013595","journal-title":"J Alzheimers Dis"},{"key":"4853_CR43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/gutjnl-2018-317431","volume":"69","author":"MS Kim","year":"2020","unstructured":"Kim MS, Kim Y, Choi H, Kim W, Park S et al (2020) Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer\u2019s disease animal model. Gut 69:283\u2013294","journal-title":"Gut"},{"key":"4853_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.638867","volume":"12","author":"AL Miller","year":"2021","unstructured":"Miller AL, Bessho S, Grando K, T\u00fckel \u00c7 (2021) Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases. Front Immunol 12:638867","journal-title":"Front Immunol"},{"key":"4853_CR45","doi-asserted-by":"crossref","unstructured":"Honarpisheh P, Reynolds CR, Blasco Conesa MP, Moruno Manchon JF, Putluri N et al (2020) Dysregulated gut homeostasis observed prior to the accumulation of the brain amyloid-\u03b2 in Tg2576 mice. Int J Mol Sci 21(5):1711","DOI":"10.3390\/ijms21051711"},{"key":"4853_CR46","doi-asserted-by":"crossref","unstructured":"Colombo AV, Sadler RK, Llovera G, Singh V, Roth S et al (2021) Microbiota-derived short chain fatty acids modulate microglia and promote Abeta plaque deposition. Elife 10:e59826","DOI":"10.7554\/eLife.59826"},{"key":"4853_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.603854","volume":"12","author":"L Cui","year":"2020","unstructured":"Cui L, Hou NN, Wu HM, Zuo X, Lian YZ et al (2020) Prevalence of Alzheimer\u2019s Disease and Parkinson\u2019s Disease in China: An Updated Systematical Analysis. Front Aging Neurosci 12:603854","journal-title":"Front Aging Neurosci"},{"key":"4853_CR48","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/mds.27063","volume":"33","author":"A Rossi","year":"2018","unstructured":"Rossi A, Berger K, Chen H, Leslie D, Mailman RB, Huang X (2018) Projection of the prevalence of Parkinson\u2019s disease in the coming decades: Revisited. Mov Disord 33:156\u2013159","journal-title":"Mov Disord"},{"key":"4853_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41531-018-0058-0","volume":"4","author":"C Marras","year":"2018","unstructured":"Marras C, Beck JC, Bower JH, Roberts E, Ritz B et al (2018) Prevalence of Parkinson\u2019s disease across North America. NPJ Parkinsons Dis 4:21","journal-title":"NPJ Parkinsons Dis"},{"key":"4853_CR50","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. The Lancet 386:896\u2013912","journal-title":"The Lancet"},{"key":"4853_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-017-1777-8","volume":"135","author":"A Lionnet","year":"2018","unstructured":"Lionnet A, Leclair-Visonneau L, Neunlist M, Murayama S, Takao M et al (2018) Does Parkinson\u2019s disease start in the gut? Acta Neuropathol 135:1\u201312","journal-title":"Acta Neuropathol"},{"key":"4853_CR52","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1007\/s11064-018-2620-x","volume":"43","author":"F Lai","year":"2018","unstructured":"Lai F, Jiang R, Xie W, Liu X, Tang Y et al (2018) Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson\u2019s Disease. Neurochem Res 43:1986\u20131999","journal-title":"Neurochem Res"},{"key":"4853_CR53","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s00415-020-09723-5","volume":"267","author":"M Lubomski","year":"2020","unstructured":"Lubomski M, Davis RL, Sue CM (2020) Gastrointestinal dysfunction in Parkinson\u2019s disease. J Neurol 267:1377\u20131388","journal-title":"J Neurol"},{"key":"4853_CR54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","volume":"7","author":"S Romano","year":"2021","unstructured":"Romano S, Savva GM, Bedarf JR, Charles IG, Hildebrand F, Narbad A (2021) Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis 7:27","journal-title":"NPJ Parkinsons Dis"},{"key":"4853_CR55","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-019-1528-y","volume":"16","author":"CH Lin","year":"2019","unstructured":"Lin CH, Chen CC, Chiang HL, Liou JM, Chang CM et al (2019) Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson\u2019s disease. J Neuroinflammation 16:129","journal-title":"J Neuroinflammation"},{"key":"4853_CR56","doi-asserted-by":"crossref","unstructured":"Vascellari S, Palmas V, Melis M, Pisanu S, Cusano R et al (2020) Gut microbiota and metabolome alterations associated with Parkinson\u2019s disease. mSystems 5(5):e00561\u201320","DOI":"10.1128\/mSystems.00561-20"},{"key":"4853_CR57","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22:657\u2013673","journal-title":"Nat Rev Immunol"},{"key":"4853_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.689723","volume":"15","author":"L Dumitrescu","year":"2021","unstructured":"Dumitrescu L, Marta D, D\u0103n\u0103u A, Lefter A, Tulb\u0103 D et al (2021) Serum and Fecal Markers of Intestinal Inflammation and Intestinal Barrier Permeability Are Elevated in Parkinson\u2019s Disease. Front Neurosci 15:689723","journal-title":"Front Neurosci"},{"key":"4853_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.617370","volume":"13","author":"X Chen","year":"2021","unstructured":"Chen X, Feng W, Ou R, Liu J, Yang J et al (2021) Evidence for Peripheral Immune Activation in Parkinson\u2019s Disease. Front Aging Neurosci 13:617370","journal-title":"Front Aging Neurosci"},{"key":"4853_CR60","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1113\/JP273269","volume":"595","author":"F Reichardt","year":"2017","unstructured":"Reichardt F, Chassaing B, Nezami BG, Li G, Tabatabavakili S et al (2017) Western diet induces colonic nitrergic myenteric neuropathy and dysmotility in mice via saturated fatty acid- and lipopolysaccharide-induced TLR4 signalling. J Physiol 595:1831\u20131846","journal-title":"J Physiol"},{"key":"4853_CR61","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/gutjnl-2018-316844","volume":"68","author":"P Perez-Pardo","year":"2019","unstructured":"Perez-Pardo P, Dodiya HB, Engen PA, Forsyth CB, Huschens AM et al (2019) Role of TLR4 in the gut-brain axis in Parkinson\u2019s disease: a translational study from men to mice. Gut 68:829\u2013843","journal-title":"Gut"},{"key":"4853_CR62","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.24448","volume":"78","author":"E Svensson","year":"2015","unstructured":"Svensson E, Horvath-Puho E, Thomsen RW, Djurhuus JC, Pedersen L et al (2015) Vagotomy and subsequent risk of Parkinson\u2019s disease. Ann Neurol 78:522\u2013529","journal-title":"Ann Neurol"},{"key":"4853_CR63","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1212\/WNL.0000000000003961","volume":"88","author":"B Liu","year":"2017","unstructured":"Liu B, Fang F, Pedersen NL, Tillander A, Ludvigsson JF et al (2017) Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study. Neurology 88:1996\u20132002","journal-title":"Neurology"},{"key":"4853_CR64","doi-asserted-by":"crossref","unstructured":"Killinger BA, Madaj Z, Sikora JW, Rey N, Haas AJ et al (2018) The vermiform appendix impacts the risk of developing Parkinson\u2019s disease. Sci Transl Med 10(465):eaar5280","DOI":"10.1126\/scitranslmed.aar5280"},{"key":"4853_CR65","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","volume":"128","author":"S Holmqvist","year":"2014","unstructured":"Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W et al (2014) Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol 128:805\u2013820","journal-title":"Acta Neuropathol"},{"key":"4853_CR66","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13024-018-0257-5","volume":"13","author":"N Uemura","year":"2018","unstructured":"Uemura N, Yagi H, Uemura MT, Hatanaka Y, Yamakado H, Takahashi R (2018) Inoculation of \u03b1-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve. Mol Neurodegener 13:21","journal-title":"Mol Neurodegener"},{"key":"4853_CR67","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.14336\/AD.2021.0418","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Chen Y, Jiang L, Zhang J, Tong X et al (2021) Intestinal Inflammation and Parkinson\u2019s Disease. Aging Dis 12:2052\u20132068","journal-title":"Aging Dis"},{"issue":"Suppl 2","key":"4853_CR68","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000518147","volume":"77","author":"M Hirayama","year":"2021","unstructured":"Hirayama M, Ohno K (2021) Parkinson\u2019s Disease and Gut Microbiota. Ann Nutr Metab 77(Suppl 2):28\u201335","journal-title":"Ann Nutr Metab"},{"key":"4853_CR69","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neures.2021.01.001","volume":"168","author":"L Rani","year":"2021","unstructured":"Rani L, Mondal AC (2021) Unravelling the role of gut microbiota in Parkinson\u2019s disease progression: Pathogenic and therapeutic implications. Neurosci Res 168:100\u2013112","journal-title":"Neurosci Res"},{"key":"4853_CR70","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A et al (2018) Multiple sclerosis Nat Rev Dis Primers 4:43","journal-title":"Multiple sclerosis Nat Rev Dis Primers"},{"key":"4853_CR71","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1016\/j.febslet.2014.09.024","volume":"588","author":"J Ochoa-Rep\u00e1raz","year":"2014","unstructured":"Ochoa-Rep\u00e1raz J, Kasper LH (2014) Gut microbiome and the risk factors in central nervous system autoimmunity. FEBS Lett 588:4214\u20134222","journal-title":"FEBS Lett"},{"key":"4853_CR72","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1080\/19490976.2017.1349041","volume":"8","author":"SK Shahi","year":"2017","unstructured":"Shahi SK, Freedman SN, Mangalam AK (2017) Gut microbiome in multiple sclerosis: The players involved and the roles they play. Gut Microbes 8:607\u2013615","journal-title":"Gut Microbes"},{"key":"4853_CR73","doi-asserted-by":"crossref","unstructured":"Akdis CA (2021) Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? Nat Rev Immunol 21(11):739\u2013751","DOI":"10.1038\/s41577-021-00538-7"},{"key":"4853_CR74","doi-asserted-by":"publisher","first-page":"12015","DOI":"10.1038\/ncomms12015","volume":"7","author":"S Jangi","year":"2016","unstructured":"Jangi S, Gandhi R, Cox LM, Li N, von Glehn F et al (2016) Alterations of the human gut microbiome in multiple sclerosis. Nat Commun 7:12015","journal-title":"Nat Commun"},{"key":"4853_CR75","doi-asserted-by":"publisher","first-page":"10713","DOI":"10.1073\/pnas.1711235114","volume":"114","author":"E Cekanaviciute","year":"2017","unstructured":"Cekanaviciute E, Yoo BB, Runia TF, Debelius JW, Singh S et al (2017) Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc Natl Acad Sci U S A 114:10713\u201310718","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4853_CR76","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/ana.26084","volume":"89","author":"LM Cox","year":"2021","unstructured":"Cox LM, Maghzi AH, Liu S, Tankou SK, Dhang FH et al (2021) Gut Microbiome in Progressive Multiple Sclerosis. Ann Neurol 89:1195\u20131211","journal-title":"Ann Neurol"},{"key":"4853_CR77","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12974-018-1136-2","volume":"15","author":"H Touil","year":"2018","unstructured":"Touil H, Kobert A, Lebeurrier N, Rieger A, Saikali P et al (2018) Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis. J Neuroinflammation 15:114","journal-title":"J Neuroinflammation"},{"key":"4853_CR78","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nm.4106","volume":"22","author":"V Rothhammer","year":"2016","unstructured":"Rothhammer V, Mascanfroni ID, Bunse L, Takenaka MC, Kenison JE et al (2016) Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med 22:586\u2013597","journal-title":"Nat Med"},{"key":"4853_CR79","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/imm.12933","volume":"154","author":"S Haase","year":"2018","unstructured":"Haase S, Haghikia A, Wilck N, M\u00fcller DN, Linker RA (2018) Impacts of microbiome metabolites on immune regulation and autoimmunity. Immunology 154:230\u2013238","journal-title":"Immunology"},{"key":"4853_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.762580","volume":"13","author":"J Shen","year":"2022","unstructured":"Shen J, Yang L, You K, Chen T, Su Z et al (2022) Indole-3-Acetic Acid Alters Intestinal Microbiota and Alleviates Ankylosing Spondylitis in Mice. Front Immunol 13:762580","journal-title":"Front Immunol"},{"key":"4853_CR81","doi-asserted-by":"crossref","unstructured":"Wang X, Liang Z, Wang S, Ma D, Zhu M, Feng J (2022) Role of gut microbiota in multiple sclerosis and potential therapeutic implications. Curr Neuropharmacol 20(7):1413\u20131426","DOI":"10.2174\/1570159X19666210629145351"},{"key":"4853_CR82","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.chest.2018.06.035","volume":"155","author":"S Niedermeyer","year":"2019","unstructured":"Niedermeyer S, Murn M, Choi PJ (2019) Respiratory Failure in Amyotrophic Lateral Sclerosis. Chest 155:401\u2013408","journal-title":"Chest"},{"key":"4853_CR83","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G et al (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3:17071","journal-title":"Nat Rev Dis Primers"},{"key":"4853_CR84","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuro.2016.06.015","volume":"61","author":"MD Wang","year":"2017","unstructured":"Wang MD, Little J, Gomes J, Cashman NR, Krewski D (2017) Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. Neurotoxicology 61:101\u2013130","journal-title":"Neurotoxicology"},{"key":"4853_CR85","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1007\/s00018-017-2509-x","volume":"74","author":"GA Weiss","year":"2017","unstructured":"Weiss GA, Hennet T (2017) Mechanisms and consequences of intestinal dysbiosis. Cell Mol Life Sci 74:2959\u20132977","journal-title":"Cell Mol Life Sci"},{"key":"4853_CR86","doi-asserted-by":"crossref","unstructured":"Milani C, Duranti S, Bottacini F, Casey E, Turroni F et al (2017) The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota. Microbiol Mol Biol Rev 81(4):e00036\u201317","DOI":"10.1128\/MMBR.00036-17"},{"key":"4853_CR87","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12916-020-01885-3","volume":"19","author":"SL Boddy","year":"2021","unstructured":"Boddy SL, Giovannelli I, Sassani M, Cooper-Knock J, Snyder MP et al (2021) The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS). BMC Med 19:13","journal-title":"BMC Med"},{"key":"4853_CR88","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/MCG.0000000000001042","volume":"2017","author":"L Mazzini","year":"2018","unstructured":"Mazzini L, Mogna L, De Marchi F, Amoruso A, Pane M et al (2018) Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies. J Clin Gastroenterol 2017:68\u201370","journal-title":"J Clin Gastroenterol"},{"key":"4853_CR89","doi-asserted-by":"publisher","first-page":"12998","DOI":"10.1038\/s41598-020-69845-8","volume":"10","author":"Q Zeng","year":"2020","unstructured":"Zeng Q, Shen J, Chen K, Zhou J, Liao Q et al (2020) The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients. Sci Rep 10:12998","journal-title":"Sci Rep"},{"key":"4853_CR90","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41586-020-2288-7","volume":"582","author":"A Burberry","year":"2020","unstructured":"Burberry A, Wells MF, Limone F, Couto A, Smith KS et al (2020) C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature 582:89\u201394","journal-title":"Nature"},{"key":"4853_CR91","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/advances\/nmx009","volume":"9","author":"H Liu","year":"2018","unstructured":"Liu H, Wang J, He T, Becker S, Zhang G et al (2018) Butyrate: A Double-Edged Sword for Health? Adv Nutr 9:21\u201329","journal-title":"Adv Nutr"},{"key":"4853_CR92","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1080\/21678421.2020.1828475","volume":"22","author":"K Nicholson","year":"2021","unstructured":"Nicholson K, Bjornevik K, Abu-Ali G, Chan J, Cortese M et al (2021) The human gut microbiota in people with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 22:186\u2013194","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"4853_CR93","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.clinthera.2016.12.014","volume":"39","author":"YG Zhang","year":"2017","unstructured":"Zhang YG, Wu S, Yi J, Xia Y, Jin D et al (2017) Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis. Clin Ther 39:322\u2013336","journal-title":"Clin Ther"},{"key":"4853_CR94","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41586-019-1443-5","volume":"572","author":"E Blacher","year":"2019","unstructured":"Blacher E, Bashiardes S, Shapiro H, Rothschild D, Mor U et al (2019) Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature 572:474\u2013480","journal-title":"Nature"},{"key":"4853_CR95","doi-asserted-by":"crossref","unstructured":"Surana NK (2019) Harnessing the microbiota to treat neurological diseases. Dialogues Clin Neurosci 21(2):159\u2013165","DOI":"10.31887\/DCNS.2019.21.2\/nsurana"},{"key":"4853_CR96","doi-asserted-by":"crossref","unstructured":"Cryan JF, O'Riordan KJ, Sandhu K, Peterson V, Dinan TG (2020) The gut microbiome in neurological disorders. Lancet Neurol 19(2):179\u2013194","DOI":"10.1016\/S1474-4422(19)30356-4"},{"key":"4853_CR97","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13073-018-0609-3","volume":"10","author":"JA Griffiths","year":"2018","unstructured":"Griffiths JA, Mazmanian SK (2018) Emerging evidence linking the gut microbiome to neurologic disorders. Genome Med 10:98","journal-title":"Genome Med"},{"key":"4853_CR98","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1136\/gutjnl-2016-312297","volume":"65","author":"G Ianiro","year":"2016","unstructured":"Ianiro G, Tilg H, Gasbarrini A (2016) Antibiotics as deep modulators of gut microbiota: between good and evil. Gut 65:1906","journal-title":"Gut"},{"key":"4853_CR99","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.molmed.2016.04.003","volume":"22","author":"S Becattini","year":"2016","unstructured":"Becattini S, Taur Y, Pamer EG (2016) Antibiotic-Induced Changes in the Intestinal Microbiota and Disease. Trends Mol Med 22:458\u2013478","journal-title":"Trends Mol Med"},{"key":"4853_CR100","doi-asserted-by":"crossref","unstructured":"Garrido\u2010Mesa N, Zarzuelo A, G\u00e1lvez J (2013) Minocycline: far beyond an antibiotic. Br J Pharmacol 169(2):337\u2013352","DOI":"10.1111\/bph.12139"},{"key":"4853_CR101","doi-asserted-by":"publisher","first-page":"15062","DOI":"10.1038\/ncomms15062","volume":"8","author":"S Leclercq","year":"2017","unstructured":"Leclercq S, Mian FM, Stanisz AM, Bindels LB, Cambier E et al (2017) Low-dose penicillin in early life induces long-term changes in murine gut microbiota, brain cytokines and behavior. Nat Commun 8:15062","journal-title":"Nat Commun"},{"key":"4853_CR102","doi-asserted-by":"crossref","unstructured":"Umeda T, Hatanaka Y, Sakai A, Tomiyama T (2021) Nasal rifampicin improves cognition in a mouse model of dementia with Lewy bodies by reducing \u03b1-Synuclein oligomers. Int J Mol Sci 22(16):8453","DOI":"10.3390\/ijms22168453"},{"key":"4853_CR103","doi-asserted-by":"publisher","first-page":"17990","DOI":"10.18632\/aging.103542","volume":"12","author":"LH Wu","year":"2020","unstructured":"Wu LH, Huang BR, Lai SW, Lin C, Lin HY et al (2020) SIRT1 activation by minocycline on regulation of microglial polarization homeostasis. Aging (Albany NY) 12:17990\u201318007","journal-title":"Aging (Albany NY)"},{"key":"4853_CR104","doi-asserted-by":"publisher","first-page":"30028","DOI":"10.1038\/srep30028","volume":"6","author":"MR Minter","year":"2016","unstructured":"Minter MR, Zhang C, Leone V, Ringus DL, Zhang X et al (2016) Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer\u2019s disease. Sci Rep 6:30028","journal-title":"Sci Rep"},{"key":"4853_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.635760","volume":"13","author":"L Medina","year":"2021","unstructured":"Medina L, Gonz\u00e1lez-Liz\u00e1rraga F, Dominguez-Meijide A, Ploper D, Parrales V et al (2021) Doxycycline Interferes With Tau Aggregation and Reduces Its Neuronal Toxicity. Front Aging Neurosci 13:635760","journal-title":"Front Aging Neurosci"},{"key":"4853_CR106","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.clineuro.2017.07.003","volume":"160","author":"H Liu","year":"2017","unstructured":"Liu H, Su W, Li S, Du W, Ma X et al (2017) Eradication of Helicobacter pylori infection might improve clinical status of patients with Parkinson\u2019s disease, especially on bradykinesia. Clin Neurol Neurosurg 160:101","journal-title":"Clin Neurol Neurosurg"},{"key":"4853_CR107","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1002\/mds.22190","volume":"23","author":"WY Lee","year":"2010","unstructured":"Lee WY, Yoon WT, Shin HY, Jeon SH, Rhee PL (2010) Helicobacter pylori infection and motor fluctuations in patients with Parkinson\u2019s disease. Mov Disord 23:1696\u20131700","journal-title":"Mov Disord"},{"key":"4853_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2019.113159","volume":"325","author":"DN Koutzoumis","year":"2020","unstructured":"Koutzoumis DN, Vergara M, Pino J, Buddendorff J, Khoshbouei H et al (2020) Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson\u2019s disease. Exp Neurol 325:113159","journal-title":"Exp Neurol"},{"key":"4853_CR109","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/19490976.2017.1353843","volume":"8","author":"SL Colpitts","year":"2017","unstructured":"Colpitts SL, Kasper EJ, Keever A, Liljenberg C, Kirby T et al (2017) A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis. Gut Microbes 8:561\u2013573","journal-title":"Gut Microbes"},{"key":"4853_CR110","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12974-019-1552-y","volume":"16","author":"T Chen","year":"2019","unstructured":"Chen T, Noto D, Hoshino Y, Mizuno M, Miyake S (2019) Butyrate suppresses demyelination and enhances remyelination. J Neuroinflammation 16:165","journal-title":"J Neuroinflammation"},{"key":"4853_CR111","doi-asserted-by":"crossref","unstructured":"Obrenovich M, Jaworski H, Tadimalla T, Mistry A, Sykes L et al (2020) The role of the microbiota\u2013gut\u2013brain axis and antibiotics in ALS and neurodegenerative diseases. Microorganisms 8(5):784","DOI":"10.3390\/microorganisms8050784"},{"key":"4853_CR112","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s12640-019-00015-z","volume":"35","author":"FV Santa-Cec\u00edlia","year":"2019","unstructured":"Santa-Cec\u00edlia FV, Leite CA, Del-Bel E, Raisman-Vozari R (2019) The Neuroprotective Effect of Doxycycline on Neurodegenerative Diseases. Neurotox Res 35:981\u2013986","journal-title":"Neurotox Res"},{"key":"4853_CR113","first-page":"4742","volume":"20","author":"S Bibb\u00f2","year":"2016","unstructured":"Bibb\u00f2 S, Ianiro G, Giorgio V, Scaldaferri F, Cammarota G (2016) The role of diet on gut microbiota composition. Eur Rev Med Pharmacol 20:4742\u20134749","journal-title":"Eur Rev Med Pharmacol"},{"key":"4853_CR114","doi-asserted-by":"crossref","unstructured":"Fernandez-Sanz P, Ruiz-Gabarre D, Garcia-Escudero V (2019) Modulating effect of diet on alzheimer\u2019s disease. Diseases 7(1):12","DOI":"10.3390\/diseases7010012"},{"key":"4853_CR115","doi-asserted-by":"crossref","unstructured":"Grosso G (2021) Nutritional psychiatry: how diet affects brain through gut microbiota. Nutrients 13(4):1282","DOI":"10.3390\/nu13041282"},{"key":"4853_CR116","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.brainresbull.2018.11.012","volume":"144","author":"TB Zhu","year":"2019","unstructured":"Zhu TB, Zhang Z, Luo P, Wang SS, Peng Y et al (2019) Lipid metabolism in Alzheimer\u2019s disease. Brain Res Bull 144:68\u201374","journal-title":"Brain Res Bull"},{"key":"4853_CR117","doi-asserted-by":"crossref","unstructured":"Tan BL, Norhaizan ME (2019) Effect of high-fat diets on oxidative stress, cellular inflammatory response and cognitive function. Nutrients 11(11):2579","DOI":"10.3390\/nu11112579"},{"key":"4853_CR118","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/978-3-319-48382-5_12","volume":"960","author":"D Yazici","year":"2017","unstructured":"Yazici D, Sezer H (2017) Insulin Resistance, Obesity and Lipotoxicity. Adv Exp Med Biol 960:277\u2013304","journal-title":"Adv Exp Med Biol"},{"key":"4853_CR119","doi-asserted-by":"crossref","unstructured":"Lin B, Hasegawa Y, Takane K, Koibuchi N, Cao C, Kim-Mitsuyama S (2016) High\u2010fat\u2010diet intake enhances cerebral amyloid angiopathy and cognitive impairment in a mouse model of Alzheimer\u2019s disease, independently of metabolic disorders. J Am Heart Assoc 5(6):e003154","DOI":"10.1161\/JAHA.115.003154"},{"key":"4853_CR120","doi-asserted-by":"crossref","unstructured":"Mirabelli M, Chiefari E, Arcidiacono B, Corigliano DM, Brunetti FS et al (2020) Mediterranean diet nutrients to turn the tide against insulin resistance and related diseases. Nutrients 12(4):1066","DOI":"10.3390\/nu12041066"},{"key":"4853_CR121","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1017\/S1368980019000612","volume":"22","author":"A Diolintzi","year":"2019","unstructured":"Diolintzi A, Panagiotakos DB, Sidossis LS (2019) From Mediterranean diet to Mediterranean lifestyle: a narrative review. Public Health Nutr 22:2703\u20132713","journal-title":"Public Health Nutr"},{"key":"4853_CR122","doi-asserted-by":"publisher","first-page":"9139","DOI":"10.3390\/nu7115459","volume":"7","author":"C Davis","year":"2015","unstructured":"Davis C, Bryan J, Hodgson J, Murphy K (2015) Definition of the Mediterranean Diet; a Literature Review. Nutrients 7:9139\u20139153","journal-title":"Nutrients"},{"key":"4853_CR123","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3233\/JAD-180184","volume":"65","author":"JE de la Rubia Ort\u00ed","year":"2018","unstructured":"de la Rubia Ort\u00ed JE, Garc\u00eda-Pardo MP, Drehmer E, Sancho Cantus D, Juli\u00e1n Rochina M et al (2018) Improvement of Main Cognitive Functions in Patients with Alzheimer\u2019s Disease after Treatment with Coconut Oil Enriched Mediterranean Diet: A Pilot Study. J Alzheimers Dis 65:577\u2013587","journal-title":"J Alzheimers Dis"},{"key":"4853_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2020.102366","volume":"50","author":"Z Paknahad","year":"2020","unstructured":"Paknahad Z, Sheklabadi E, Derakhshan Y, Bagherniya M, Chitsaz A (2020) The effect of the Mediterranean diet on cognitive function in patients with Parkinson\u2019s disease: A randomized clinical controlled trial. Complement Ther Med 50:102366","journal-title":"Complement Ther Med"},{"key":"4853_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.109913","volume":"101","author":"AK Kraeuter","year":"2020","unstructured":"Kraeuter AK, Phillips R, Sarnyai Z (2020) Ketogenic therapy in neurodegenerative and psychiatric disorders: From mice to men. Prog Neuropsychopharmacol Biol Psychiatry 101:109913","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"4853_CR126","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1528-1167.2007.00915.x","volume":"48","author":"KJ Bough","year":"2007","unstructured":"Bough KJ, Rho JM (2007) Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 48:43\u201358","journal-title":"Epilepsia"},{"key":"4853_CR127","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13195-021-00783-x","volume":"13","author":"MCL Phillips","year":"2021","unstructured":"Phillips MCL, Deprez LM, Mortimer GMN, Murtagh DKJ, McCoy S et al (2021) Randomized crossover trial of a modified ketogenic diet in Alzheimer\u2019s disease. Alzheimers Res Ther 13:51","journal-title":"Alzheimers Res Ther"},{"key":"4853_CR128","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/mds.27390","volume":"33","author":"MCL Phillips","year":"2018","unstructured":"Phillips MCL, Murtagh DKJ, Gilbertson LJ, Asztely FJS, Lynch CDP (2018) Low-fat versus ketogenic diet in Parkinson\u2019s disease: A pilot randomized controlled trial. Mov Disord 33:1306\u20131314","journal-title":"Mov Disord"},{"key":"4853_CR129","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/j.celrep.2016.05.009","volume":"15","author":"IY Choi","year":"2016","unstructured":"Choi IY, Piccio L, Childress P, Bollman B, Ghosh A et al (2016) A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms. Cell Rep 15:2136\u20132146","journal-title":"Cell Rep"},{"key":"4853_CR130","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ana.25661","volume":"87","author":"AC Ludolph","year":"2020","unstructured":"Ludolph AC, Dorst J, Dreyhaupt J, Weishaupt JH, Kassubek J et al (2020) Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis. Ann Neurol 87:206\u2013216","journal-title":"Ann Neurol"},{"key":"4853_CR131","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/md19030165","volume":"19","author":"S Fakhri","year":"2021","unstructured":"Fakhri S, Yarmohammadi A, Yarmohammadi M, Farzaei MH, Echeverria J (2021) Marine Natural Products: Promising Candidates in the Modulation of Gut-Brain Axis towards Neuroprotection. Mar Drugs 19:165","journal-title":"Mar Drugs"},{"key":"4853_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2019.100997","volume":"75","author":"TT Zhang","year":"2019","unstructured":"Zhang TT, Xu J, Wang YM, Xue CH (2019) Health benefits of dietary marine DHA\/EPA-enriched glycerophospholipids. Prog Lipid Res 75:100997","journal-title":"Prog Lipid Res"},{"key":"4853_CR133","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1146\/annurev-pharmtox-010919-023628","volume":"60","author":"C Long-Smith","year":"2020","unstructured":"Long-Smith C, O\u2019Riordan KJ, Clarke G, Stanton C, Dinan TG, Cryan JF (2020) Microbiota-Gut-Brain Axis: New Therapeutic Opportunities. Annu Rev Pharmacol Toxicol 60:477\u2013502","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"4853_CR134","doi-asserted-by":"publisher","first-page":"6764919","DOI":"10.1155\/2019\/6764919","volume":"2019","author":"CX Zhang","year":"2019","unstructured":"Zhang CX, Wang HY, Chen TX (2019) Interactions between Intestinal Microflora\/Probiotics and the Immune System. Biomed Res Int 2019:6764919","journal-title":"Biomed Res Int"},{"key":"4853_CR135","doi-asserted-by":"crossref","unstructured":"Cristofori F, Dargenio VN, Dargenio C, Miniello VL, Francavilla R (2021) Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: a door to the body. Front Immunol 12:578386","DOI":"10.3389\/fimmu.2021.578386"},{"key":"4853_CR136","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ et al (2014) Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506\u2013514","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4853_CR137","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41575-020-0344-2","volume":"17","author":"KS Swanson","year":"2020","unstructured":"Swanson KS, Gibson GR, Hutkins R, Reimer RA, Reid G et al (2020) The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol 17:687\u2013701","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4853_CR138","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.3168\/jds.2019-18003","volume":"103","author":"C Li","year":"2020","unstructured":"Li C, Niu Z, Zou M, Liu S, Wang M et al (2020) Probiotics, prebiotics, and synbiotics regulate the intestinal microbiota differentially and restore the relative abundance of specific gut microorganisms. J Dairy Sci 103:5816\u20135829","journal-title":"J Dairy Sci"},{"key":"4853_CR139","doi-asserted-by":"crossref","unstructured":"Markowiak P, \u015ali\u017cewska K (2017) Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients 9(9):1021","DOI":"10.3390\/nu9091021"},{"key":"4853_CR140","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/j.clnu.2018.11.034","volume":"38","author":"OR Tamtaji","year":"2019","unstructured":"Tamtaji OR, Heidari-Soureshjani R, Mirhosseini N, Kouchaki E, Bahmani F et al (2019) Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer\u2019s disease: A randomized, double-blind, controlled trial. Clin Nutr 38:2569\u20132575","journal-title":"Clin Nutr"},{"key":"4853_CR141","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201900636","volume":"64","author":"J Sun","year":"2020","unstructured":"Sun J, Xu J, Yang B, Chen K, Kong Y et al (2020) Effect of Clostridium butyricum against Microglia-Mediated Neuroinflammation in Alzheimer\u2019s Disease via Regulating Gut Microbiota and Metabolites Butyrate. Mol Nutr Food Res 64:e1900636","journal-title":"Mol Nutr Food Res"},{"key":"4853_CR142","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1038\/s41598-017-02587-2","volume":"7","author":"L Bonfili","year":"2017","unstructured":"Bonfili L, Cecarini V, Berardi S, Scarpona S, Suchodolski JS et al (2017) Microbiota modulation counteracts Alzheimer\u2019s disease progression influencing neuronal proteolysis and gut hormones plasma levels. Sci Rep 7:2426","journal-title":"Sci Rep"},{"key":"4853_CR143","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.apsb.2019.07.001","volume":"10","author":"X Yang","year":"2020","unstructured":"Yang X, Yu D, Xue L, Li H, Du J (2020) Probiotics modulate the microbiota-gut-brain axis and improve memory deficits in aged SAMP8 mice. Acta Pharm Sin B 10:475\u2013487","journal-title":"Acta Pharm Sin B"},{"key":"4853_CR144","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.18632\/aging.102927","volume":"12","author":"V Castelli","year":"2020","unstructured":"Castelli V, d\u2019Angelo M, Lombardi F, Alfonsetti M, Antonosante A et al (2020) Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson\u2019s disease models. Aging (Albany NY) 12:4641\u20134659","journal-title":"Aging (Albany NY)"},{"key":"4853_CR145","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.clnu.2018.05.018","volume":"38","author":"OR Tamtaji","year":"2019","unstructured":"Tamtaji OR, Taghizadeh M, Daneshvar Kakhaki R, Kouchaki E, Bahmani F et al (2019) Clinical and metabolic response to probiotic administration in people with Parkinson\u2019s disease: A randomized, double-blind, placebo-controlled trial. Clin Nutr 38:1031\u20131035","journal-title":"Clin Nutr"},{"key":"4853_CR146","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-3-030-55035-6_6","volume":"1286","author":"H Atabati","year":"2021","unstructured":"Atabati H, Yazdanpanah E, Mortazavi H, Bajestani SG, Raoofi A et al (2021) Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis. Adv Exp Med Biol 1286:87\u2013105","journal-title":"Adv Exp Med Biol"},{"key":"4853_CR147","doi-asserted-by":"crossref","unstructured":"Hutchinson AN, Bergh C, Kruger K, S\u0171sserov\u00e1 M, Allen J et al (2021) The effect of probiotics on health outcomes in the elderly: a systematic review of randomized, placebo-controlled studies. Microorganisms 9(6):1344","DOI":"10.3390\/microorganisms9061344"},{"key":"4853_CR148","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1080\/07315724.2017.1347074","volume":"36","author":"OR Tamtaji","year":"2017","unstructured":"Tamtaji OR, Kouchaki E, Salami M, Aghadavod E, Akbari E et al (2017) The Effects of Probiotic Supplementation on Gene Expression Related to Inflammation, Insulin, and Lipids in Patients With Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial. J Am Coll Nutr 36:660\u2013665","journal-title":"J Am Coll Nutr"},{"key":"4853_CR149","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.clnu.2016.08.015","volume":"36","author":"E Kouchaki","year":"2017","unstructured":"Kouchaki E, Tamtaji OR, Salami M, Bahmani F, Daneshvar Kakhaki R et al (2017) Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial. Clin Nutr 36:1245\u20131249","journal-title":"Clin Nutr"},{"key":"4853_CR150","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/ana.25244","volume":"83","author":"SK Tankou","year":"2018","unstructured":"Tankou SK, Regev K, Healy BC, Tjon E, Laghi L et al (2018) A probiotic modulates the microbiome and immunity in multiple sclerosis. Ann Neurol 83:1147\u20131161","journal-title":"Ann Neurol"},{"key":"4853_CR151","doi-asserted-by":"crossref","unstructured":"Calvo-Barreiro L, Eixarch H, Ponce-Alonso M, Castillo M, Lebr\u00f3n-Gal\u00e1n R et al (2020) A commercial probiotic induces tolerogenic and reduces pathogenic responses in experimental autoimmune encephalomyelitis. Cells 9(4):906","DOI":"10.3390\/cells9040906"},{"key":"4853_CR152","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jfda.2018.12.011","volume":"27","author":"CJ Chang","year":"2019","unstructured":"Chang CJ, Lin TL, Tsai YL, Wu TR, Lai WF et al (2019) Next generation probiotics in disease amelioration. J Food Drug Anal 27:615\u2013622","journal-title":"J Food Drug Anal"},{"key":"4853_CR153","unstructured":"Tekin R. Fecal Microbiota Transplantation. Proc EKMUD 2015, 2015"},{"key":"4853_CR154","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13020-019-0253-x","volume":"14","author":"H Du","year":"2019","unstructured":"Du H, Kuang TT, Qiu S, Xu T, Gang Huan CL et al (2019) Fecal medicines used in traditional medical system of China: a systematic review of their names, original species, traditional uses, and modern investigations. Chin Med 14:31","journal-title":"Chin Med"},{"key":"4853_CR155","doi-asserted-by":"publisher","first-page":"630","DOI":"10.7326\/M14-2693","volume":"162","author":"D Drekonja","year":"2015","unstructured":"Drekonja D, Reich J, Gezahegn S, Greer N, Shaukat A et al (2015) Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review. Ann Intern Med 162:630\u2013638","journal-title":"Ann Intern Med"},{"key":"4853_CR156","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/19490976.2017.1290757","volume":"8","author":"AR Weingarden","year":"2017","unstructured":"Weingarden AR, Vaughn BP (2017) Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease. Gut Microbes 8:238\u2013252","journal-title":"Gut Microbes"},{"key":"4853_CR157","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3748\/wjg.v26.i8.777","volume":"26","author":"A Gupta","year":"2020","unstructured":"Gupta A, Saha S, Khanna S (2020) Therapies to modulate gut microbiota: Past, present and future. World J Gastroenterol 26:777\u2013788","journal-title":"World J Gastroenterol"},{"key":"4853_CR158","doi-asserted-by":"publisher","first-page":"175909142110162","DOI":"10.1177\/17590914211016217","volume":"13","author":"Y Kang","year":"2021","unstructured":"Kang Y, Kang X, Zhang H, Liu Q, Yang H, Fan W (2021) Gut Microbiota and Parkinson\u2019s Disease: Implications for Faecal Microbiota Transplantation Therapy. ASN Neuro 13:17590914211016216","journal-title":"ASN Neuro"},{"key":"4853_CR159","doi-asserted-by":"crossref","unstructured":"Sun MF, Zhu YL, Zhou ZL, Jia XB, Xu YD et al (2018) Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway. Brain Behav Immun 70:48\u201360","DOI":"10.1016\/j.bbi.2018.02.005"},{"key":"4853_CR160","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12934-021-01589-0","volume":"20","author":"XY Kuai","year":"2021","unstructured":"Kuai XY, Yao XH, Xu LJ, Zhou YQ, Zhang LP et al (2021) Evaluation of fecal microbiota transplantation in Parkinson\u2019s disease patients with constipation. Microb Cell Fact 20:98","journal-title":"Microb Cell Fact"},{"key":"4853_CR161","first-page":"2018","volume":"69","author":"MS Kim","year":"2019","unstructured":"Kim MS, Kim Y, Choi H, Kim W, Mook-Jung I (2019) Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer\u2019s disease animal model. Gut 69:2018\u2013317431","journal-title":"Gut"},{"key":"4853_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110449","volume":"129","author":"H Wang","year":"2020","unstructured":"Wang H, Yang F, Xin R, Cui D, Sun Y (2020) The gut microbiota attenuate neuroinflammation in manganese exposure by inhibiting cerebral NLRP3 inflammasome. Biomed Pharmacother 129:110449","journal-title":"Biomed Pharmacother"},{"key":"4853_CR163","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41398-019-0525-3","volume":"9","author":"J Sun","year":"2019","unstructured":"Sun J, Xu J, Ling Y, Wang F, Gong T et al (2019) Fecal microbiota transplantation alleviated Alzheimer\u2019s disease-like pathogenesis in APP\/PS1 transgenic mice. Transl Psychiatry 9:189","journal-title":"Transl Psychiatry"},{"issue":"779\u201394","key":"4853_CR164","volume":"26","author":"S Liu","year":"2019","unstructured":"Liu S, Rezende RM, Moreira TG, Tankou SK, Cox LM et al (2019) Oral Administration of miR-30d from Feces of MS Patients Suppresses MS-like Symptoms in Mice by Expanding Akkermansia muciniphila. Cell Host Microbe 26(779\u201394):e8","journal-title":"Cell Host Microbe"},{"key":"4853_CR165","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fcimb.2020.00098","volume":"10","author":"KEW Vendrik","year":"2020","unstructured":"Vendrik KEW, Ooijevaar RE, de Jong PRC, Laman JD, van Oosten BW et al (2020) Fecal Microbiota Transplantation in Neurological Disorders. Front Cell Infect Microbiol 10:98","journal-title":"Front Cell Infect Microbiol"},{"key":"4853_CR166","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3389\/fneur.2019.01021","volume":"10","author":"J Mandrioli","year":"2019","unstructured":"Mandrioli J, Amedei A, Cammarota G, Niccolai E, Zucchi E et al (2019) FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis. Front Neurol 10:1021","journal-title":"Front Neurol"},{"key":"4853_CR167","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1854640","volume":"12","author":"JE Green","year":"2020","unstructured":"Green JE, Davis JA, Berk M, Hair C, Loughman A et al (2020) Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis. Gut Microbes 12:1\u201325","journal-title":"Gut Microbes"},{"key":"4853_CR168","doi-asserted-by":"crossref","unstructured":"Cammarota G, Ianiro G, Bibb\u00f2 S, Gas Ba Rrini A (2014) Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation? Int Emerg Med 9(4):365\u2013373","DOI":"10.1007\/s11739-014-1069-4"},{"key":"4853_CR169","doi-asserted-by":"crossref","unstructured":"Hardt S (2008) The role of microbiota in infectious disease. Trends Microbiol 16(3):107\u2013114","DOI":"10.1016\/j.tim.2007.12.008"},{"key":"4853_CR170","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","volume":"381","author":"Z DeFilipp","year":"2019","unstructured":"DeFilipp Z, Bloom PP, Torres Soto M, Mansour MK, Sater MRA et al (2019) Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant. N Engl J Med 381:2043\u20132050","journal-title":"N Engl J Med"},{"key":"4853_CR171","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ijmm.2016.03.006","volume":"306","author":"KS Smirnov","year":"2016","unstructured":"Smirnov KS, Maier TV, Walker A, Heinzmann SS, Forcisi S et al (2016) Challenges of metabolomics in human gut microbiota research. Int J Med Microbiol 306:266\u2013279","journal-title":"Int J Med Microbiol"},{"key":"4853_CR172","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.tim.2016.06.008","volume":"24","author":"JW Arnold","year":"2016","unstructured":"Arnold JW, Roach J, Azcarate-Peril MA (2016) Emerging Technologies for Gut Microbiome Research. Trends Microbiol 24:887\u2013901","journal-title":"Trends Microbiol"},{"key":"4853_CR173","doi-asserted-by":"crossref","unstructured":"Watterson WJ, Tanyeri M, Watson AR, Cham CM, Tay S (2020) Droplet-based high-throughput cultivation for accurate screening of antibiotic resistant gut microbes. ELife 9:e56998","DOI":"10.7554\/eLife.56998"},{"key":"4853_CR174","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/mas.21553","volume":"38","author":"H Luan","year":"2019","unstructured":"Luan H, Wang X, Cai Z (2019) Mass spectrometry-based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders. Mass Spectrom Rev 38:22\u201333","journal-title":"Mass Spectrom Rev"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04853-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-023-04853-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04853-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T15:07:19Z","timestamp":1725376039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-023-04853-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":174,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["4853"],"URL":"https:\/\/doi.org\/10.1007\/s11010-023-04853-6","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,3]]},"assertion":[{"value":"5 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statements"}},{"value":"N\/A.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"N\/A.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal and research involving recombinant DNA studies"}}]}}